JP2016512229A5 - - Google Patents

Download PDF

Info

Publication number
JP2016512229A5
JP2016512229A5 JP2015562544A JP2015562544A JP2016512229A5 JP 2016512229 A5 JP2016512229 A5 JP 2016512229A5 JP 2015562544 A JP2015562544 A JP 2015562544A JP 2015562544 A JP2015562544 A JP 2015562544A JP 2016512229 A5 JP2016512229 A5 JP 2016512229A5
Authority
JP
Japan
Prior art keywords
formulation
chewable
fat
lipid
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015562544A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016512229A (ja
JP6378702B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2014/059911 external-priority patent/WO2014141223A1/en
Publication of JP2016512229A publication Critical patent/JP2016512229A/ja
Publication of JP2016512229A5 publication Critical patent/JP2016512229A5/ja
Application granted granted Critical
Publication of JP6378702B2 publication Critical patent/JP6378702B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015562544A 2013-03-15 2014-03-17 チュアブル製剤 Active JP6378702B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361793676P 2013-03-15 2013-03-15
US61/793,676 2013-03-15
PCT/IB2014/059911 WO2014141223A1 (en) 2013-03-15 2014-03-17 Chewable formulation

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018141273A Division JP6841799B2 (ja) 2013-03-15 2018-07-27 チュアブル製剤

Publications (3)

Publication Number Publication Date
JP2016512229A JP2016512229A (ja) 2016-04-25
JP2016512229A5 true JP2016512229A5 (enExample) 2017-04-13
JP6378702B2 JP6378702B2 (ja) 2018-08-22

Family

ID=51535990

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2015562544A Active JP6378702B2 (ja) 2013-03-15 2014-03-17 チュアブル製剤
JP2018141273A Active JP6841799B2 (ja) 2013-03-15 2018-07-27 チュアブル製剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2018141273A Active JP6841799B2 (ja) 2013-03-15 2018-07-27 チュアブル製剤

Country Status (8)

Country Link
US (2) US9314478B2 (enExample)
EP (1) EP2968569A4 (enExample)
JP (2) JP6378702B2 (enExample)
CN (2) CN111803465B (enExample)
AU (5) AU2014229179C1 (enExample)
BR (1) BR112015023435B1 (enExample)
CA (1) CA2906295C (enExample)
WO (1) WO2014141223A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111803465B (zh) * 2013-03-15 2023-05-09 阿根塔创新有限公司 可咀嚼配制物
DE202014006415U1 (de) * 2014-08-12 2015-11-13 Boehringer Ingelheim International Gmbh Wasserlösliches Granulat zur Herstellung einer Trinklösung
JP2017533959A (ja) * 2014-11-03 2017-11-16 ゾエティス・サービシーズ・エルエルシー 嗜好性が高く咀嚼可能な獣医学的な組成物
US9808010B2 (en) * 2015-07-06 2017-11-07 Virbac Corporation Chewable composition
EP3308773A1 (en) * 2016-10-11 2018-04-18 Recordati Industria Chimica E Farmaceutica SPA Formulations of cysteamine and cysteamine derivatives
CN110996920A (zh) 2017-07-26 2020-04-10 太杰先软嚼有限责任公司 用于兽医应用的无淀粉软咀嚼物
US12115135B2 (en) * 2018-04-11 2024-10-15 Richard Postrel Anti-aging therapy for canines and other domesticated animals
MX2020004105A (es) * 2017-12-08 2020-09-22 Hoffmann La Roche Formulacion farmaceutica.
AR116524A1 (es) * 2018-10-04 2021-05-19 Elanco Tiergesundheit Ag Potenciación de tratamiento de helmintos
US20200146318A1 (en) * 2019-09-27 2020-05-14 Société des Produits Nestlé S.A. Edible chew for a human child and methods of making and using the edible chew
US12599160B2 (en) 2019-12-09 2026-04-14 Nicoventures Trading Limited Lipid-containing oral composition
EP3878436A1 (en) 2020-03-09 2021-09-15 Bayer Animal Health GmbH Soft chewable formed body for the administration to animals
KR102941104B1 (ko) * 2020-05-06 2026-03-19 마아즈, 인코오포레이티드 의약품의 투여를 위한 기호성 지지 조성물
AU2021335500A1 (en) 2020-09-04 2023-05-04 Elanco Us Inc. Palatable formulations
US20230405034A1 (en) * 2020-09-30 2023-12-21 Procaps S.A. Formulation of ivermectin in soft gelatin capsules
JP2024514002A (ja) * 2021-04-15 2024-03-27 ジボダン エス エー 味改変剤
NL2028708B1 (en) * 2021-07-13 2023-01-18 Stabican B V Process for preparing cannabinoid-containing particles
FR3138315A1 (fr) 2022-07-27 2024-02-02 Virbac Produit à usage vétérinaire et procédé pour sa fabrication
WO2025029582A2 (en) * 2023-08-01 2025-02-06 Rubicon Scientific, Llc Maintaining diethylcarbamazine in an extruded daily ration animal feed product
WO2025111456A1 (en) * 2023-11-21 2025-05-30 Bimini, Llc Compositions for inducing saliva and release of calcium chelators and antimicrobials in oral cavity

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2857897B2 (ja) * 1989-12-11 1999-02-17 株式会社山海 膨化成形食品
US5380535A (en) 1991-05-28 1995-01-10 Geyer; Robert P. Chewable drug-delivery compositions and methods for preparing the same
US5296209A (en) 1992-01-17 1994-03-22 Colgate Palmolive Company Pet chew product having oral care properties
PT760648E (pt) 1994-05-20 2002-04-29 Janssen Pharmaceutica Nv Tabletes de flubendazole de mastigacao para animais domesticos
CN1188646A (zh) * 1997-01-24 1998-07-29 赫彻斯特股份公司 制备味道被掩盖的抗菌活性的喹喏酮衍生物制剂
US5904937A (en) * 1997-10-03 1999-05-18 Fmc Corporation Taste masked pharmaceutical compositions
US6387381B2 (en) * 1998-09-24 2002-05-14 Ez-Med Company Semi-moist oral delivery system
US6672252B2 (en) 2002-01-31 2004-01-06 Sergeant's Pet Products, Inc. Pet chew
US20050271708A1 (en) 2002-03-05 2005-12-08 Thombre Avinash G Palatable controlled-release formulation for companion animals
US20040151759A1 (en) 2002-08-16 2004-08-05 Douglas Cleverly Non-animal product containing veterinary formulations
US20040037869A1 (en) 2002-08-16 2004-02-26 Douglas Cleverly Non-animal product containing veterinary formulations
EP1440622B1 (en) * 2003-01-27 2014-03-05 Nestec S.A. Use of expanded constituents and manufacture of products therefrom
AU2008201605B2 (en) 2003-07-30 2010-04-29 Novartis Ag Palatable ductile chewable veterinary composition
AR045142A1 (es) 2003-07-30 2005-10-19 Novartis Ag Composicion veterinaria masticable ductil de buen sabor
EP1523892A1 (en) 2003-10-17 2005-04-20 Paragon Products B.V. i.o. Pet's chew
BRPI0509673A (pt) 2004-04-07 2007-10-09 Intervet Int Bv composição para o tratamento de parasitas, forma de dosagem farmacêutica, método para tratar um organismo, e, processos para introduzir pelo menos um aditivo em um organismo, para fabricar uma composição, para liberar um aditivo em um organismo, e, para conformar um produto macio mastigável
EP1602285A1 (en) 2004-06-04 2005-12-07 Gaines Treats Limited A process for preparing a chewable pet food
AU2006223579A1 (en) 2005-03-11 2006-09-21 Genentech, Inc. Gene disruptions, compositions and methods relating thereto
US7348027B2 (en) 2005-04-08 2008-03-25 Bayer Healthcare Llc Taste masked veterinary formulation
US20070148282A1 (en) 2005-12-02 2007-06-28 Mars, Inc. Performance Oral Snack
US20070128251A1 (en) 2005-12-07 2007-06-07 Piedmont Pharmaceuticals, Inc. Process for manufacturing chewable dosage forms for drug delivery and products thereof
US7955632B2 (en) * 2005-12-07 2011-06-07 Bayer B.V. Process for manufacturing chewable dosage forms for drug delivery and products thereof
EP1800545A1 (en) 2005-12-23 2007-06-27 Nestec S.A. Pet food and processes of producing the same
ES2303446B1 (es) 2006-07-03 2009-07-28 Viscofan, S.A. Producto masticable y/o comestible para mascotas y animales.
MX2009002552A (es) 2006-09-07 2009-03-30 Merial Ltd Formulaciones de antibiotico veterinarias masticables blandas, de tableta e inyectables de larga accion, novedosas.
US8455025B2 (en) 2010-04-21 2013-06-04 Petmatrix LLC Edible pet chew made from a single initially malleable sheet
RU2476076C2 (ru) * 2007-02-26 2013-02-27 Револимер Лимитед Лечебная жевательная резинка
EP2124600A1 (en) * 2007-02-26 2009-12-02 Revolymer Limited Medicated chewing gum
AU2008247327B2 (en) * 2007-05-07 2013-08-22 Jurox Pty Ltd Improved dosage form and process
US20080293645A1 (en) 2007-05-25 2008-11-27 Schneider Lawrence F Antiparasitic combination and method for treating domestic animals
CN101677592B (zh) * 2007-06-01 2013-09-11 卡夫食品环球品牌有限责任公司 包括三醋精的中心填充物胶基糖组合物
WO2008154528A2 (en) 2007-06-13 2008-12-18 E. I. Du Pont De Nemours And Company Isoxazoline insecticides
TWI430995B (zh) 2007-06-26 2014-03-21 Du Pont 萘異唑啉無脊椎有害動物控制劑
DK2162016T3 (da) * 2007-07-06 2012-07-23 Gumlink As Tyggegummigranuler til komprimattyggegummi
TWI556741B (zh) 2007-08-17 2016-11-11 英特威特國際股份有限公司 異唑啉組成物及其作為抗寄生蟲藥上的應用
AU2009289464B2 (en) 2008-09-04 2015-12-10 Farnam Companies, Inc. Chewable sustained release formulations
CN102149290A (zh) * 2008-09-12 2011-08-10 索莱有限责任公司 功能性食物糊剂
UA105648C2 (uk) * 2008-12-05 2014-06-10 Баєр Інтеллекчуел Проперті Гмбх Екструдати з голчатими активними речовинами
EP2576523B1 (en) 2010-05-27 2016-01-13 E. I. du Pont de Nemours and Company Crystalline form of 4-[5 - [3 -chloro-5 -(trifluoromethyl)phenyl] -4,5 -dihydro-5 -(trifluoromethyl)-3 - isoxazolyl]-n-[2-oxo-2-[(2,2,2-trifluoroethyl)amino]ethyl]-1- naphthalenecarboxamide
HUE042360T2 (hu) 2011-09-12 2019-06-28 Merial Inc Izoxazolin hatóanyagot tartalmazó parazitaellenes készítmények, ezek elõállítása és alkalmazása
WO2013068371A1 (en) 2011-11-08 2013-05-16 Intervet International B.V. Soft chewable dosage form compositions of cannabinoid receptor type 1 (cb-1) antagonists
AP2014007874A0 (en) * 2012-02-06 2014-08-31 Merial Ltd Parasiticidal oral veterinary compositions comprising systemetically- acting active agents, methods and uses thereof
CN111803465B (zh) * 2013-03-15 2023-05-09 阿根塔创新有限公司 可咀嚼配制物

Similar Documents

Publication Publication Date Title
JP6841799B2 (ja) チュアブル製剤
JP2015500241A5 (enExample)
JP2008540690A5 (enExample)
JP2022541916A (ja) ソフトチュアブル獣医学用投与形態
CA2598991A1 (en) Enhanced flavor-release comestible compositions and methods for same
JP2016535030A5 (enExample)
CN105360143A (zh) 一种蚂蚁诱杀胶饵
JP2013545802A5 (enExample)
HRP20160446T1 (hr) Farmaceutski pripravci koji sadrže derivat kamptotecina
WO1995008931A1 (fr) Composition et systeme a administration orale pour animaux
JP2021120387A (ja) 薬学的有効成分を含むチュアブル組成物
RU2018143832A (ru) Способ получения формованных изделий для введения животным
WO2014033230A1 (fr) Compositions pour administration orale aux animaux, leurs procedes d'obtention et leurs utilisations
CA2886086C (en) Orodispersible films having quick dissolution times for therapeutic and food use
JP2017001966A5 (enExample)
JP5022896B2 (ja) ガバペンチン含有医薬組成物
RU2015129081A (ru) Гелевые композиции
RU2012149275A (ru) Пищевые составы с медленным выделением
JP4096914B2 (ja) 浴剤用水性ゲル
JP2006182669A (ja) 口腔内貼付剤
WO2005090461A2 (en) Thermoplastic films and methods for making
JP6566574B2 (ja) 軟膏基剤および軟膏
CN121041205A (zh) 基于燕窝酸与甘草酸复合的喷雾型温敏凝胶及其制备方法
JP2021106507A (ja) ゼラチン含有組成物及び吸湿抑制方法
NZ737238B2 (en) Oral solid formulation containing irinotecan and method of preparing the same